Long-chain fatty acids (LCFAs) are vital components of our diet and contribute to a plethora of processes including metabolic energy generation and storage, plasma membrane synthesis, and protein anchoring. In addition, LCFAs have hormone-like properties since they can profoundly affect gene expression via nuclear receptors such as HNF4 and the PPAR family (reviewed in Ref. 45), trigger insulin release through activation of the G-protein-coupled receptor (GPCR) GPR40 by -cells (89), affect the innate immune response by modulating toll-like receptor (TLR) signaling in a number of cell types (reviewed in Ref. 53), and suppress food intake by inhibiting the release of neuropeptide Y (NPY) and Agouti-related protein (AgRP) in a subpopulation of hypothalamic neurons (reviewed in Refs. 51, 78). Because of the physiological significance of LCFAs, chronic imbalances in lipid fluxes and metabolism often cause a variety of (metabolic) abnormalities and pathologies, including hyperlipidemia, obesity, Type 2 diabetes mellitus, nonalcoholic fatty liver disease, heart disease, and cancer (16,37,50,54,56,57,64,73).Although in some tissues and cell types LCFAs can signal through GPCRs or TLRs (53, 89), they typically have to first cross the plasma membrane to elicit their effects. In general, the uptake of fatty acids from the circulation into cells include the sequence of 1) localized generation of free fatty acids through hydrolysis of triglyceride (TG)-rich lipoproteins by lipases inside the endothelial lumen and binding of fatty acids to albumin, 2) fatty acid dissociation from albumin followed by binding to plasma membrane proteins or integration into the lipid bilayer, 3) their transport across the plasma membranes, and 4) their intracellular association with fatty acid binding and acyl-CoA binding proteins (FABPs and ACBPs, respectively) (1, 33, 91), as illustrated in FIGURE 1A. The mechanism by which fatty acids cross the plasma membrane has been debated for several years. Because fatty acids are predominantly lipophilic, it was initially proposed that they traverse the lipid bilayer by diffusion (passive flip-flop) without the involvement of protein mediators (35,68). However, many organs and cell types display a rapid, saturable, substrate-specific, and hormonally regulated LCFA uptake mechanism indicative of protein-mediated processes (8,10,83). Although the occurrence of both LCFA uptake processes are now widely accepted, during the past years considerable data have demonstrated that protein-mediated transport accounts for the majority of fatty acid uptake by tissues with high LCFA metabolism and storage such as skeletal muscle (99), adipose tissue (75), liver (22,24,26,82,93,95), and heart (81, 94). Particularly, at physiological concentrations and serum-to-albumin ratios, the concentration of unbound fatty acids is low (7.5 nM) and >90% of LCFA uptake occurs via the protein-mediated pathway (71). The crucial role of proteins for efficient LCFA uptake has been underscored by a number of knockout (KO) model systems...